Published in Am J Respir Crit Care Med on June 01, 1996
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.48
The clinical features of the overlap between COPD and asthma. Respir Res (2011) 2.29
Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med (2011) 2.06
Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax (1997) 2.04
The microbiome of the lung. Transl Res (2012) 1.59
Risk of current asthma among adult smokers with respiratory syncytial virus illnesses in early life. Am J Respir Crit Care Med (2014) 1.54
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
The Saudi Initiative for Asthma. Ann Thorac Med (2009) 1.31
Cough threshold in patients with chronic obstructive pulmonary disease. Thorax (1999) 1.29
Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2009) 1.27
Do symptoms predict COPD in smokers? Chest (2010) 1.22
The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2012) 1.22
Environmental tobacco smoke exposure and asthma in adults. Environ Health Perspect (1999) 1.22
Convergence of the epidemiology and pathology of COPD. Thorax (2005) 1.17
Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health (2014) 1.11
Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med (2010) 1.11
Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax (1999) 1.10
A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax (2006) 1.05
Airway hyperresponsiveness and COPD mortality. Thorax (2001) 1.05
Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome. Korean J Intern Med (2015) 1.02
The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2005) 1.01
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax (2003) 0.99
Update on the "Dutch hypothesis" for chronic respiratory disease. Thorax (1998) 0.97
Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease. PLoS One (2010) 0.92
Overlap Between Asthma and COPD: Where the Two Diseases Converge. Allergy Asthma Immunol Res (2010) 0.90
Is obesity associated with an increased risk for airway hyperresponsiveness and development of asthma? Allergy Asthma Clin Immunol (2008) 0.88
Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease. Mediators Inflamm (2001) 0.87
Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD. Thorax (2003) 0.87
Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness. Thorax (2002) 0.86
Airflow obstruction in young adults in Canada. Can Respir J (2007) 0.86
Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis (2014) 0.85
The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2016) 0.85
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Non-invasive biomarkers and pulmonary function in smokers. Int J Chron Obstruct Pulmon Dis (2008) 0.84
Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung. Pharmaceuticals (Basel) (2012) 0.82
Bronchial hyperresponsiveness in women with chronic obstructive pulmonary disease related to wood smoke. Int J Chron Obstruct Pulmon Dis (2012) 0.82
Higher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study. PLoS One (2013) 0.81
The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res (2014) 0.80
Genome-Wide Association Study Identification of Novel Loci Associated with Airway Responsiveness in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol (2015) 0.79
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. Clin Chest Med (2015) 0.76
Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial. PLoS One (2015) 0.75
Inhaled steroids for COPD? Thorax (2001) 0.75
Bronchial responsiveness to dry air hyperventilation in smokers may predict decline in airway status using indirect methods. Lung (2013) 0.75
The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease. Sci Rep (2016) 0.75
The Dutch hypothesis meets genomics. Am J Respir Crit Care Med (2015) 0.75
The relationship between inspiratory lung function parameters and airway hyper-responsiveness in subjects with mild to moderate COPD. BMC Res Notes (2012) 0.75
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Heart rate variability associated with particulate air pollution. Am Heart J (1999) 6.21
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am J Public Health (1993) 3.38
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Oxygen saturation, pulse rate, and particulate air pollution: A daily time-series panel study. Am J Respir Crit Care Med (1999) 3.10
Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 2.98
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85
Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope (1996) 2.78
The one-year surgical outcome after prism adaptation for the management of acquired esotropia. Ophthalmology (1996) 2.76
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect (2001) 2.38
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Bronchodilator response in the lung health study over 11 yrs. Eur Respir J (2005) 2.26
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis (1991) 2.16
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol (1998) 2.10
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
A study of the test-retest reliability of ten olfactory tests. Chem Senses (1995) 1.88
SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys (1986) 1.87
Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol (1995) 1.86
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med (1994) 1.83
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med (2000) 1.79
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest (1993) 1.70
Predicting similarity and categorization from identification. J Exp Psychol Gen (1991) 1.70
The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol (1988) 1.65
Effect of fiberoptic bronchoscopy on respiratory performance in patients with chronic airways obstruction. Thorax (1975) 1.60
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum (1992) 1.59
Haemophilus influenzae and haemophilus parainfluenzae in chronic obstructive pulmonary disease. Lancet (1976) 1.57
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease. Neurology (2007) 1.53
The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis (1992) 1.53
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci (1996) 1.53
Myasthenia gravis and upper airway obstruction. Chest (1996) 1.51
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest (1993) 1.49
Perfluorocarbon priming and surfactant: physiologic and pathologic effects. Crit Care Med (1999) 1.48
Physician knowledge in the use of canister nebulizers. Chest (1983) 1.47
Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest (1996) 1.45
Immunocompetent cells from the lower respiratory tract of normal human lungs. J Clin Invest (1975) 1.44
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood. Am Rev Respir Dis (1977) 1.41
Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J Neurosci (2000) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Partial liquid ventilation: a comparison using conventional and high-frequency techniques in an animal model of acute respiratory failure. Crit Care Med (1997) 1.40
The relationship between alveolar oxygen tension and the single-breath carbon monoxide diffusing capacity. Am Rev Respir Dis (1986) 1.39
Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol (1977) 1.38
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther (1993) 1.38
Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology (Berl) (1995) 1.36
Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci (1994) 1.35
Variables associated with changes in spirometry in patients with obstructive lung diseases. Am J Med (1979) 1.35
Catecholamine theories of reward: a critical review. Brain Res (1978) 1.35
Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav (1982) 1.34
Social support for smoking cessation and abstinence: the Lung Health Study. Lung Health Study Research Group. Addict Behav (1995) 1.34
Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science (1976) 1.34
Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med (1998) 1.33
Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis: treatment with high-concentration oxygen. Chest (2000) 1.33
Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial. Am Heart J (1984) 1.33
Olfactory dysfunction in patients with head trauma. Arch Neurol (1997) 1.32
Airway function in sarcoidosis. Am J Med (1977) 1.32
The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am J Respir Crit Care Med (2001) 1.29
Tracheal and neck position influence upper airway airflow dynamics by altering airway length. J Appl Physiol (1985) (1993) 1.28